Cloud-Clone expands feline cell portfolio for veterinary research

Cloud-Clone said it has assembled primary feline cells across 14 research fields to support studies of feline disease, pathogen research, drug screening and regenerative medicine. The company is positioning the portfolio as a way to reduce cross-species bias in lab models and improve data quality in companion-animal research.

Why it matters: - Primary feline cells can better preserve native biology than immortalized rodent or human cell lines. - That matters for feline disease studies, where cross-species differences can distort protein expression and signaling results. - The portfolio is designed to support veterinary drug discovery, pathogen research, toxicity testing and regenerative-medicine work.

What happened: - Cloud-Clone introduced a broad primary feline cell portfolio sourced from diverse feline tissues. - The collection is organized into 14 major research areas. - The lineup is meant to give researchers a reference set for selecting cell models for feline disease mechanism studies, pathogen characterization and veterinary screening. - Cloud-Clone said the cells are produced through validated tissue isolation, gradient digestion, purification and culture workflows under rigorous quality control.

The details: - Bone research models include articular chondrocytes, meniscus fibrocartilage cells, auricular chondrocytes, tendon cells, skeletal muscle cells, lingual skeletal muscle cells, annulus fibrosus cells and nucleus pulposus cells. - Those bone-related cells support work on osteoarthritis, cartilage loss, tendon injury, muscle atrophy, disc degeneration and tissue repair. - Nervous-system models include brain astrocytes, meningeal cells, sciatic-nerve peripheral fibroblasts, brain vascular pericytes, olfactory astrocytes and olfactory supporting cells. - Those cells are intended for studies of neurodegeneration, neural trauma, neural development and pathogen-linked neural damage. - Reproductive-system models include uterine smooth-muscle cells, ovarian fibroblasts, endometrial epithelial cells and ovarian granulosa cells. - Cardiovascular cells include cardiac microvascular endothelial cells, pericardial fibroblasts, aortic smooth-muscle cells, pericardial mesothelial cells and aortic adventitial fibroblasts. - Respiratory models include pulmonary fibroblasts, tracheal smooth-muscle cells, tracheal epithelial cells and tracheal fibroblasts. - Digestive-system cells are derived from oesophageal, gastrointestinal, hepatic and pancreatic tissues. - Urinary-system models include renal tubular epithelial cells, renal-cortical epithelial cells, bladder smooth-muscle cells, bladder stromal fibroblasts, ureteral smooth-muscle cells and urethral epithelial cells. - Skin and mucosal models include adult dermal fibroblasts, adult epidermal keratinocytes, neonatal epidermal keratinocytes, nasal-mucosal epithelial cells, nasal-mucosal fibroblasts and gingival fibroblasts. - Ocular models include corneal stromal cells, corneal epithelial cells and retinal pigment epithelial cells. - Immune and haematopoietic models include peripheral-blood mononuclear cells, splenic mononuclear cells and bone-marrow mononuclear cells. - Lymphoid and glandular models include thymic fibroblasts, thymic epithelial cells and splenic fibroblasts. - Adipose-metabolism models are positioned for research on adipocyte differentiation, lipid turnover, fat accumulation and adipose-tissue inflammation. - Endocrine-system models are intended for work on hormone secretion and disorders such as feline diabetes and thyroid disease. - Stem-cell models are presented as tools for tissue repair, organ regeneration and cell-therapy development. - Cloud-Clone said the cells maintain native biological features with high viability and purity. - The company said the portfolio supports basic veterinary mechanistic studies, feline pathogen isolation and characterization, vaccine development, antiviral drug screening, veterinary safety assessment and regenerative-medicine research.

Between the lines: - The pitch is less about a single product and more about building a standardized species-specific toolkit for feline science. - That framing reflects a practical gap in veterinary research: many labs still rely on non-feline models that can weaken translational relevance. - The portfolio also signals demand for pre-clinical feline tools as companion-animal medicine and zoonotic-pathogen work expand.

What's next: - Cloud-Clone is directing researchers to contact its global sales and technical support team for specifications, technical data and ordering details. - The company is also using its broader research-tool business to support uptake of the feline cell line-up across veterinary, virology and regenerative-medicine workflows.

The bottom line: - Cloud-Clone is betting that species-matched primary feline cells will help researchers produce more reliable data and move feline biomedical studies closer to real-world biology.